MiR-148a-3p targets known oncogenes and important signal pathways for tumour growth like Wnt and epithelial-mesenchymal transition (EMT) [58, 63], RAS-like protein1 (RALBP1) [60], DNMT1 [57, 61], c-Myc [63], SMAD2 [62], c-Met, snail, and other targets [64, 65]. The gene discussed is SMAD2; the disease is neoplasm.